Skip to main navigation Skip to search Skip to main content

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

  • Niall C. Tebbutt
  • , Kate Wilson
  • , Val J. Gebski
  • , Michelle M. Cummins
  • , Diana Zannino
  • , Guy A. Van Hazel
  • , Bridget Robinson
  • , Adam Broad
  • , Vinod Ganju
  • , Stephen P. Ackland
  • , Garry Forgeson
  • , David Cunningham
  • , Mark P. Saunders
  • , Martin R. Stockler
  • , Yujo Chua
  • , John R. Zalcberg
  • , R. John Simes
  • , Timothy J. Price

Research output: Contribution to journal › Article › peer-review

383 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology